NCT00829413View on ClinicalTrials.gov

SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization

PHASE3CompletedINTERVENTIONAL
Enrollment

353

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Liver Neoplasms
Interventions
DRUG

SonoVue®

SonoVue (2.4 mL)

Trial Locations (1)

08540

Bracco Diagnostics Inc., Princeton

Sponsors
All Listed Sponsors
lead

Bracco Diagnostics, Inc

INDUSTRY